Vistapharm Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Vistapharm

Access the complete profile.

Vistapharm Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	200 Connell Dr Ste 1000 Berkeley Heights, NJ 07922

Note: Revenues for privately held companies are statistical evaluations.


Vistapharm's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Vistapharm's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Vistapharm is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry, NAICS Code 4242.

Vistapharm Annual Revenue and Growth Rate

Vistapharm	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Over $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Vistapharm's revenues are gauged from an analysis of company filings.

Vistapharm's Income Statement (based on Industry Averages)

Vistapharm P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Vistapharm is developing and marketing. Vistapharm doesn't have any recent trademark applications, indicating Vistapharm is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
V VERTICE SPECIALTY GROUP Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of clinical trials	12/01/2020
THYQUIDITY (LEVOTHYROXINE SODIUM) ORAL SOLUTION 100 MCG/5ML pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency, myxedema and thyroid tumors	12/01/2020
ONSOLADAY pharmaceutical preparations for the treatment of hypothyroidism, thyroid hormone deficiency and thyroid cancer	07/01/2020

See all trademarks and details in the Full Report.

Market Share of Vistapharm's Largest Competitors

A competitive analysis shows these companies are in the same general field as Vistapharm, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AMERISOURCEBERGEN	Conshohocken, PA	100
MCKESSON	Irving, TX	58
CARDINAL HEALTH 119	Dublin, OH	42
TAKEDA PHARMACEUTICALS AMERICA	Lexington, MA	31
CATALENT PHARMA SOLUTIONS	Somerset, NJ	13
OWENS & MINOR DISTRIBUTION	Mechanicsville, VA	11
J M SMITH	Spartanburg, SC	3
DAIICHI SANKYO	Basking Ridge, NJ	3
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	2

Nearby Competitors

These companies are similar in business line and location to Vistapharm. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
DAIICHI SANKYO	Basking Ridge, NJ	100
HIKMA PHARMACEUTICALS USA	Berkeley Heights, NJ	90
ASEMBIA	Florham Park, NJ	32
SHIONOGI	Florham Park, NJ	14
VISTAPHARM	Berkeley Heights, NJ	8
PHARMACOSMOS THERAPEUTICS	Morristown, NJ	7

Future Competition: Vistapharm's Fastest Growing Competitors

These companies are in the same general field as Vistapharm and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)